Assyro AI

Orange Book product · Generic (ANDA)

SUFENTANIL CITRATE

SUFENTANIL CITRATE

Generic (ANDA)ANDA 074534TE APRX HOSPIRA

At a glance

Dec 11, 1996

Approved

Generic (ANDA)

Application

AP

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Dec 11, 1996

    29 yr 11 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

SUFENTANIL CITRATE

Strength

EQ 0.05MG BASE/ML

Dosage form

INJECTABLE

Route

INJECTION

TE code

AP

Application

ANDA 074534

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of SUFENTANIL CITRATE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.